Effect of Bromelain , Curcumin and Epigallocatechin in the treatment of outpatient Covid-19 patients : A Randomized, Double-blind, Placebo-controlled study to Evaluate the Efficacy and Safety of the Bromelain, Curcumin and Epigallocatechin in the treatment of outpatient Covid-19 patients

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 29. Nov. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Covid 19. Pneumonia due to SARS-associated coronavirus;J12.81
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2021-08-16, Last updated: 2022-11-24

ICTRP ID:

IRCT20210724051971N1

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG007847041